High Growth Tech Stocks To Watch In September 2024

In the last week, the Australian market has stayed flat while the Real Estate sector gained 3.3%, and over the past 12 months, it has risen by 11% with earnings forecasted to grow by 12% annually. In this context, identifying high-growth tech stocks that can capitalize on these favorable conditions is crucial for investors looking to maximize their returns in September 2024.

Top 10 High Growth Tech Companies In Australia

Name	Revenue Growth	Earnings Growth	Growth Rating
Clinuvel Pharmaceuticals	22.41%	27.42%	★★★★★★
Pureprofile	14.94%	80.73%	★★★★★☆
AVA Risk Group	32.56%	118.83%	★★★★★★
ImExHS	20.47%	111.20%	★★★★★★
DUG Technology	10.90%	32.21%	★★★★★☆
Pointerra	56.62%	126.45%	★★★★★★
Careteq	34.13%	126.60%	★★★★★☆
Wrkr	36.31%	100.29%	★★★★★★
Adveritas	57.98%	144.21%	★★★★★★
SiteMinder	19.39%	60.31%	★★★★★☆

Click here to see the full list of 61 stocks from our ASX High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

Nuix (ASX:NXL)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Nuix Limited provides investigative analytics and intelligence software solutions across the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a market cap of A$1.79 billion.

Operations: Nuix generates revenue primarily from its Software & Programming segment, which accounted for A$220.62 million. The company focuses on delivering investigative analytics and intelligence software solutions globally.

Nuix has shown impressive growth, reporting a 20.90% increase in annual revenue to AUD 220.62 million and achieving profitability with a net income of AUD 5.03 million for the year ending June 30, 2024. Their strategic partnership with Veritone enhances their eDiscovery and compliance solutions, leveraging AI technology to handle complex data sets efficiently. The company has also focused on innovation, allocating significant resources to R&D expenditures which totaled AUD 15 million this fiscal year, representing a commitment to continuous improvement and technological advancement in the software industry.

• Get an in-depth perspective on Nuix's performance by reading our health report here.

• Gain insights into Nuix's past trends and performance with our Past report.

Pro Medicus (ASX:PME)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pro Medicus Limited is a healthcare informatics company that develops and supplies imaging software and radiology information system (RIS) software to hospitals, imaging centers, and healthcare groups across Australia, North America, and Europe with a market cap of A$16.40 billion.

Operations: Pro Medicus Limited generates revenue primarily from producing integrated software applications for the healthcare industry, amounting to A$161.50 million. The company's operations span Australia, North America, and Europe.

Pro Medicus, a prominent player in the healthcare software sector, reported a revenue increase of 16.8% to AUD 166.33 million for the fiscal year ending June 2024, compared to AUD 127.33 million the previous year. Net income surged by 36.5%, reaching AUD 82.79 million from last year's AUD 60.65 million, reflecting strong operational performance and market demand for their imaging solutions. Notably, R&D expenses were significant at AUD 15 million, underscoring a commitment to innovation that supports their high-quality earnings and future growth prospects in AI-driven medical imaging technologies.

• Navigate through the intricacies of Pro Medicus with our comprehensive health report here.

• Learn about Pro Medicus' historical performance.

WiseTech Global (ASX:WTC)

Simply Wall St Growth Rating: ★★★★★☆

Overview: WiseTech Global Limited develops and provides software solutions for the logistics execution industry across multiple regions including the Americas, Asia Pacific, Europe, the Middle East, and Africa, with a market cap of A$42.18 billion.

Operations: WiseTech Global Limited generates revenue primarily through its Internet Software & Services segment, which reported A$1.04 billion. The company focuses on providing software solutions tailored to the logistics execution industry across various regions globally.

WiseTech Global's recent earnings report highlighted a 27.5% increase in net income to AUD 262.8 million, driven by robust revenue growth of 27.5%, reaching AUD 1.04 billion for the fiscal year ending June 2024. The company has demonstrated a strong commitment to innovation, with R&D expenses amounting to AUD 161 million, representing approximately 15% of total revenue and underscoring their focus on advancing logistics software solutions. With projected annual profit growth of 23.9%, WiseTech continues to outpace the broader Australian market's expected growth rate of 12.2%.

• Unlock comprehensive insights into our analysis of WiseTech Global stock in this health report.

• Review our historical performance report to gain insights into WiseTech Global's's past performance.

Make It Happen

• Embark on your investment journey to our 61 ASX High Growth Tech and AI Stocks selection here.
• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com